These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 34709299)

  • 1. Novel Cardioprotective Effect of L-Carnitine on Obese Diabetic Mice: Regulation of Chemerin and CMKLRI Expression in Heart and Adipose Tissues.
    Amiri R; Tabandeh MR; Hosseini SA
    Arq Bras Cardiol; 2021 Oct; 117(4):715-725. PubMed ID: 34709299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. L-carnitine improves metabolic disorders and regulates apelin and apelin receptor genes expression in adipose tissue in diabetic rats.
    Ranjbar Kohan N; Tabandeh MR; Nazifi S; Soleimani Z
    Physiol Rep; 2020 Dec; 8(23):e14641. PubMed ID: 33278072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of weight loss and exercise on chemerin serum concentrations and adipose tissue expression in human obesity.
    Chakaroun R; Raschpichler M; Klöting N; Oberbach A; Flehmig G; Kern M; Schön MR; Shang E; Lohmann T; Dreßler M; Fasshauer M; Stumvoll M; Blüher M
    Metabolism; 2012 May; 61(5):706-14. PubMed ID: 22136911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemerin is a novel adipokine associated with obesity and metabolic syndrome.
    Bozaoglu K; Bolton K; McMillan J; Zimmet P; Jowett J; Collier G; Walder K; Segal D
    Endocrinology; 2007 Oct; 148(10):4687-94. PubMed ID: 17640997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum Chemerin in Obese Children and Adolescents Before and After L-Carnitine Therapy: Relation to Nonalcoholic Fatty Liver Disease and Other Features of Metabolic Syndrome.
    Hamza RT; Elkabbany ZA; Shedid AM; Hamed AI; Ebrahim AO
    Arch Med Res; 2016 Oct; 47(7):541-549. PubMed ID: 28262196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Irbesartan on Chemerin in the Renal Tissues of Diabetic Rats.
    Yu QX; Zhang H; Xu WH; Hao F; Liu SL; Bai MM; Mu JW; Zhang HJ
    Kidney Blood Press Res; 2015; 40(5):467-77. PubMed ID: 26394118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The increase of serum chemerin concentration is mainly associated with the increase of body mass index in obese, non-diabetic subjects.
    Sledzinski T; Korczynska J; Hallmann A; Kaska L; Proczko-Markuszewska M; Stefaniak T; Sledzinski M; Swierczynski J
    J Endocrinol Invest; 2013 Jun; 36(6):428-34. PubMed ID: 23211604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased levels of chemerin and its receptor, chemokine-like receptor-1, in obesity are related to inflammation: tumor necrosis factor-α stimulates mRNA levels of chemerin in visceral adipocytes from obese patients.
    Catalán V; Gómez-Ambrosi J; Rodríguez A; Ramírez B; Rotellar F; Valentí V; Silva C; Gil MJ; Salvador J; Frühbeck G
    Surg Obes Relat Dis; 2013; 9(2):306-14. PubMed ID: 22154272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The expression of chemerin and the influence of sitagliptin on its expression in non-alcoholic fatty liver disease rats complicated with prediabetes].
    Zhang L; Gao XF; Wang YH
    Zhonghua Yi Xue Za Zhi; 2018 Aug; 98(30):2407-2413. PubMed ID: 30138985
    [No Abstract]   [Full Text] [Related]  

  • 10. Chemerin exacerbates glucose intolerance in mouse models of obesity and diabetes.
    Ernst MC; Issa M; Goralski KB; Sinal CJ
    Endocrinology; 2010 May; 151(5):1998-2007. PubMed ID: 20228173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemerin expression in Chinese pregnant women with and without gestational diabetes mellitus.
    Li XM; Ji H; Li CJ; Wang PH; Yu P; Yu DM
    Ann Endocrinol (Paris); 2015 Feb; 76(1):19-24. PubMed ID: 25627894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of aerobic exercise and dieting on chemerin and its receptor CMKLR1 in the livers of type 2 diabetic rats].
    Lin XJ; Yang HF; Wang XH
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2017 May; 33(5):426-430. PubMed ID: 29926587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The chemerin production changes in obese patients with different carbohydrate metabolism state].
    Vasilenko MA; Kirienkova EV; Skuratovskaya DA; Zatolokin PA; Mironyuk NI; Litvinova LS
    Biomed Khim; 2017 Nov; 63(6):582-590. PubMed ID: 29251622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemerin-induced macrophages pyroptosis in fetal brain tissue leads to cognitive disorder in offspring of diabetic dams.
    Liang Z; Han L; Sun D; Chen Y; Wu Q; Zhang L; Zhou M; Chen D
    J Neuroinflammation; 2019 Nov; 16(1):226. PubMed ID: 31733653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rosiglitazone ameliorates diabetic nephropathy by reducing the expression of Chemerin and ChemR23 in the kidney of streptozotocin-induced diabetic rats.
    Hu W; Yu Q; Zhang J; Liu D
    Inflammation; 2012 Aug; 35(4):1287-93. PubMed ID: 22350950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gpr1 is an active chemerin receptor influencing glucose homeostasis in obese mice.
    Rourke JL; Muruganandan S; Dranse HJ; McMullen NM; Sinal CJ
    J Endocrinol; 2014 Aug; 222(2):201-15. PubMed ID: 24895415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating adipokines and mRNA expression in adipose tissue and the placenta in women with gestational diabetes mellitus.
    Tsiotra PC; Halvatsiotis P; Patsouras K; Maratou E; Salamalekis G; Raptis SA; Dimitriadis G; Boutati E
    Peptides; 2018 Mar; 101():157-166. PubMed ID: 29337272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inverse Relationship of the CMKLR1 Relative Expression and Chemerin Serum Levels in Obesity with Dysmetabolic Phenotype and Insulin Resistance.
    Corona-Meraz FI; Navarro-Hernández RE; Ruíz-Quezada SL; Madrigal-Ruíz PM; Castro-Albarrán J; Chavarría-Ávila E; Guzmán-Ornelas MO; Gómez-Bañuelos E; Petri MH; Ramírez-Cedano JI; Aguilar-Aldrete ME; Ríos-Ibarra C; Vázquez-Del Mercado M
    Mediators Inflamm; 2016; 2016():3085390. PubMed ID: 27239101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The adipokine Chemerin and Fetuin-A Serum Levels in Type 2 Diabetes Mellitus: Relation to Obesity and Inflammatory Markers.
    El-Deeb TS; Bakkar SM; Eltoony L; Zakhary MM; Kamel AA; Nafee AM; Hetta HF
    Egypt J Immunol; 2018 Jan; 25(1):191-202. PubMed ID: 30243011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemerin is a novel adipocyte-derived factor inducing insulin resistance in primary human skeletal muscle cells.
    Sell H; Laurencikiene J; Taube A; Eckardt K; Cramer A; Horrighs A; Arner P; Eckel J
    Diabetes; 2009 Dec; 58(12):2731-40. PubMed ID: 19720798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.